FDA Inspection 983894 — Reproductive Technologies, Inc.
The FDA completed an inspection of Reproductive Technologies, Inc. on September 8, 2016 in Berkeley, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 8, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Berkeley, CA (United States)